{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:58:02Z","timestamp":1787320682905,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"32","license":[{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["160076"],"award-info":[{"award-number":["160076"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["F30CA224986"],"award-info":[{"award-number":["F30CA224986"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["C06RR15482"],"award-info":[{"award-number":["C06RR15482"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ara Parsegian Medical Research Foundation and Abraham Lincoln Fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s41388-019-0842-2","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T12:02:39Z","timestamp":1562846559000},"page":"6003-6016","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton"],"prefix":"10.1038","volume":"38","author":[{"given":"Laura R.","family":"Hardy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa R.","family":"Pergande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Esparza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly N.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayat","family":"\u00d6ny\u00fcksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Cologna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna E.","family":"Burdette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,11]]},"reference":[{"key":"842_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7\u201330.","journal-title":"CA Cancer J Clin."},{"key":"842_CR2","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/modpathol.2011.3","volume":"24","author":"A Ozcan","year":"2011","unstructured":"Ozcan A, Shen SS, Hamilton C, Anjana K, Coffey D, Krishnan B, et al. PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study. Mod Pathol. 2011;24:751\u201364.","journal-title":"Mod Pathol."},{"key":"842_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fonc.2014.00053","volume":"4","author":"CW McCloskey","year":"2014","unstructured":"McCloskey CW, Goldberg RL, Carter LE, Gamwell LF, Al-Hujaily EM, Collins O, et al. A new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell population. Front Oncol. 2014;4:53.","journal-title":"Front Oncol."},{"key":"842_CR4","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/carcin\/bgt357","volume":"35","author":"PS Tanwar","year":"2014","unstructured":"Tanwar PS, Mohapatra G, Chiang S, Engler DA, Zhang L, Kaneko-Tarui T, et al. Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer. Carcinogenesis. 2014;35:546\u201353.","journal-title":"Carcinogenesis"},{"key":"842_CR5","doi-asserted-by":"publisher","first-page":"32785","DOI":"10.18632\/oncotarget.9051","volume":"7","author":"LH Rodgers","year":"2016","unstructured":"Rodgers LH, \u00d3 hAinmhire E, Young AN, Burdette JE. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium. Oncotarget. 2016;7:32785\u201395.","journal-title":"Oncotarget"},{"key":"842_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-292","volume":"14","author":"T Di Palma","year":"2014","unstructured":"Di Palma T, Lucci V, de Cristofaro T, Filippone MG, Zannini M. A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells. Bmc Cancer. 2014;14:292.","journal-title":"Bmc Cancer"},{"key":"842_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/path.1000","volume":"195","author":"JM Piek","year":"2001","unstructured":"Piek JM, van Diest PJ, Zweemer RP, Jansen JW, Poort-Keesom RJ, Menko FH, et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol. 2001;195:451\u20136.","journal-title":"J Pathol."},{"key":"842_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00962-1","volume":"8","author":"SI Labidi-Galy","year":"2017","unstructured":"Labidi-Galy SI, Papp E, Hallberg D, Niknafs N, Adleff V, Noe M, et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nat Commun. 2017;8:1093.","journal-title":"Nat Commun."},{"key":"842_CR9","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","volume":"42","author":"RJ Kurman","year":"2011","unstructured":"Kurman RJ, Shih I-M. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2013shifting the paradigm. Hum Pathol. 2011;42:918\u201331.","journal-title":"Hum Pathol."},{"key":"842_CR10","doi-asserted-by":"publisher","unstructured":"Elias KM, Emori MM, Westerling T, Long H, Budina-Kolomets A, Li F, et al. Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors. JCI Insight. 2016;1. https:\/\/doi.org\/10.1172\/jci.insight.87988 .","DOI":"10.1172\/jci.insight.87988"},{"key":"842_CR11","doi-asserted-by":"publisher","first-page":"108316","DOI":"10.18632\/oncotarget.22718","volume":"8","author":"EK Adler","year":"2017","unstructured":"Adler EK, Corona RI, Lee JM, Rodriguez-Malave N, Mhawech-Fauceglia P, Sowter H, et al. The PAX8 cistrome in epithelial ovarian cancer. Oncotarget. 2017;8:108316\u201332.","journal-title":"Oncotarget"},{"key":"842_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/ng0598-87","volume":"19","author":"A Mansouri","year":"1998","unstructured":"Mansouri A, Chowdhury K, Gruss P. Follicular cells of the thyroid gland require Pax8 gene function. Nat Genet. 1998;19:87\u201390.","journal-title":"Nat Genet."},{"key":"842_CR13","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.1038\/onc.2011.190","volume":"30","author":"CG Li","year":"2011","unstructured":"Li CG, Nyman JE, Braithwaite AW, Eccles MR. PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein. Oncogene. 2011;30:4824\u201334.","journal-title":"Oncogene"},{"issue":"17","key":"842_CR14","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1038\/s41388-017-0040-z","volume":"37","author":"Dima Ghannam-Shahbari","year":"2018","unstructured":"Ghannam-Shahbari D, Jacob E, Kakun RR, Wasserman T, Korsensky L, Sternfeld O, et al. PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma. Oncogene. 2018;37:2213.","journal-title":"Oncogene"},{"key":"842_CR15","doi-asserted-by":"publisher","first-page":"32810","DOI":"10.18632\/oncotarget.9053","volume":"7","author":"J Haley","year":"2016","unstructured":"Haley J, Tomar S, Pulliam N, Xiong S, Perkins SM, Karpf AR, et al. Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease. Oncotarget. 2016;7:32810\u201320.","journal-title":"Oncotarget"},{"issue":"5","key":"842_CR16","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1093\/carcin\/bgt003","volume":"34","author":"Shelby M. King","year":"2013","unstructured":"King SM, Quartuccio SM, Vanderhyden BC, Burdette JE. Early transformative changes in normal ovarian surface epithelium induced by oxidative stress require akt upregulation, DNA damage, and epithelial-stromal interaction. Carcinogenesis. 2013;34:1125\u201333.","journal-title":"Carcinogenesis"},{"key":"842_CR17","doi-asserted-by":"publisher","first-page":"20500","DOI":"10.18632\/oncotarget.3985","volume":"6","author":"SL Eddie","year":"2015","unstructured":"Eddie SL, Quartuccio SM, \u00d3 hAinmhir E, Moyle-Heyrman G, Lantvit DD, Wei J-J, et al. Tumorigenesis and peritoneal colonization from fallopian tube epithelium. Oncotarget. 2015;6:20500\u201312.","journal-title":"Oncotarget"},{"issue":"15","key":"842_CR18","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1038\/s41388-017-0097-8","volume":"37","author":"Angela Russo","year":"2018","unstructured":"Russo A, Czarnecki AA, Dean M, Modi DA, Lantvit DD, Hardy L, et al. PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation. Oncogene. 2018;37:1976.","journal-title":"Oncogene"},{"key":"842_CR19","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8:2281\u2013308.","journal-title":"Nat Protoc."},{"key":"842_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fonc.2015.00154","volume":"5","author":"MP Endsley","year":"2015","unstructured":"Endsley MP, Moyle-Heyrman G, Karthikeyan S, Lantvit DD, Davis DA, Wei J-J, et al. Spontaneous transformation of murine oviductal epithelial cells: a model system to investigate the onset of fallopian-derived tumors. Front Oncol. 2015;5:154.","journal-title":"Front Oncol."},{"key":"842_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wi\u015bniewski","year":"2009","unstructured":"Wi\u015bniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6:359\u201362.","journal-title":"Nat Methods"},{"key":"842_CR22","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1021\/pr500893m","volume":"13","author":"TS Batth","year":"2014","unstructured":"Batth TS, Francavilla C, Olsen JV. Off-line high-ph reversed-phase fractionation for in-depth phosphoproteomics. J Proteome Res. 2014;13:6176\u201386.","journal-title":"J Proteome Res."},{"key":"842_CR23","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.jchromb.2011.01.032","volume":"879","author":"E Gokce","year":"2011","unstructured":"Gokce E, Andrews GL, Dean RA, Muddiman DC. Increasing proteome coverage with offline RP HPLC coupled to online RP nanoLC-MS. J Chromatogr B Anal Technol Biomed Life Sci. 2011;879:610\u20134.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci."},{"key":"842_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/978-1-4939-6747-6_23","volume":"1550","author":"R Adusumilli","year":"2017","unstructured":"Adusumilli R, Mallick P. Data conversion with ProteoWizard msConvert. Methods Mol Biol Clifton NJ. 2017;1550:339\u201368.","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"842_CR25","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1038\/nprot.2006.427","volume":"1","author":"S-E Ong","year":"2006","unstructured":"Ong S-E, Mann M. A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat Protoc. 2006;1:2650\u201360.","journal-title":"Nat Protoc"},{"key":"842_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1530\/ERC-11-0107","volume":"18","author":"SM King","year":"2011","unstructured":"King SM, et al. The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer. Endocr Relat Cancer. 2011;18:627\u201342.","journal-title":"Endocr Relat Cancer"},{"key":"842_CR27","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.1016\/S0021-9258(18)98335-3","volume":"268","author":"G Martiny-Baron","year":"1993","unstructured":"Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, et al. Selective inhibition of protein kinase C isozymes by the indolocarbazole G\u00f6 6976. J Biol Chem. 1993;268:9194\u20137.","journal-title":"J Biol Chem."},{"key":"842_CR28","doi-asserted-by":"crossref","unstructured":"Ke N, Wang X, Xu X, Abassi YA. The xCELLigence system for real-time and label-free monitoring of cell viability. In: Mammalian cell viability. Springer; 2011, pp 33\u201343.","DOI":"10.1007\/978-1-61779-108-6_6"},{"key":"842_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijpharm.2018.12.001","volume":"556","author":"K Esparza","year":"2019","unstructured":"Esparza K, Onyuksel H. Development of co-solvent freeze-drying method for the encapsulation of water-insoluble thiostrepton in sterically stabilized micelles. Int J Pharm. 2019;556:21\u201329.","journal-title":"Int J Pharm."},{"key":"842_CR30","doi-asserted-by":"publisher","first-page":"41929","DOI":"10.18632\/oncotarget.9740","volume":"7","author":"T de Cristofaro","year":"2016","unstructured":"de Cristofaro T, Di Palma T, Soriano AA, Monticelli A, Affinito O, Cocozza S, et al. Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma. Oncotarget. 2016;7:41929\u201347.","journal-title":"Oncotarget"},{"key":"842_CR31","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nchem.1114","volume":"3","author":"NS Hegde","year":"2011","unstructured":"Hegde NS, Sanders DA, Rodriguez R, Balasubramanian S. The transcription factor FOXM1 is a cellular target of the natural product thiostrepton. Nat Chem. 2011;3:725\u201331.","journal-title":"Nat Chem"},{"key":"842_CR32","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1158\/1535-7163.MCT-11-0536","volume":"10","author":"M Wang","year":"2011","unstructured":"Wang M, Gartel AL. Micelle-encapsulated thiostrepton as an effective nanomedicine for inhibiting tumor growth and for suppressing FOXM1 in human xenografts. Mol Cancer Ther. 2011;10:2287\u201397.","journal-title":"Mol Cancer Ther."},{"issue":"6","key":"842_CR33","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00432-014-1872-3","volume":"141","author":"Lizhu Jiang","year":"2014","unstructured":"Jiang L, Wu X, Wang P, Wen T, Yu C, Wei L, et al. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol. 2015;141:971\u201381.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"842_CR34","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/jps.20150","volume":"93","author":"B Ashok","year":"2004","unstructured":"Ashok B, Arleth L, Hjelm RP, Rubinstein I, Ony\u00fcksel H. In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation. J Pharm Sci. 2004;93:2476\u201387.","journal-title":"J Pharm Sci."},{"key":"842_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2012.06.002","volume":"163","author":"SB Lim","year":"2012","unstructured":"Lim SB, Banerjee A, \u00d6ny\u00fcksel H. Improvement of drug safety by the use of lipid-based nanocarriers. J Control Release J Control Release Soc. 2012;163:34\u201345.","journal-title":"J Control Release J Control Release Soc"},{"key":"842_CR36","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","volume":"34","author":"AR Laury","year":"2010","unstructured":"Laury AR, Hornick JL, Perets R, Krane JF, Corson J, Drapkin R, et al. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol. 2010;34:627\u201335.","journal-title":"Am J Surg Pathol."},{"key":"842_CR37","doi-asserted-by":"publisher","first-page":"12372","DOI":"10.1073\/pnas.1109363108","volume":"108","author":"HW Cheung","year":"2011","unstructured":"Cheung HW, Cowley GS, Weir BA, Boehm JS, Rusin S, Scott JA, et al. Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc Natl Acad Sci USA. 2011;108:12372\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"842_CR38","doi-asserted-by":"publisher","first-page":"17218","DOI":"10.1074\/jbc.M115.639773","volume":"290","author":"N Musrap","year":"2015","unstructured":"Musrap N, Tuccitto A, Karagiannis GS, Saraon P, Batruch I, Diamandis EP. Comparative proteomics of ovarian cancer aggregate formation reveals an increased expression of calcium-activated chloride channel regulator 1 (CLCA1). J Biol Chem 2015;290:17218\u201327.","journal-title":"J Biol Chem"},{"key":"842_CR39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jprot.2016.06.009","volume":"151","author":"ML Grassi","year":"2017","unstructured":"Grassi ML, Palma C, de S, Thom\u00e9 CH, Lanfredi GP, Poersch A, Fa\u00e7a VM. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control. J Proteom. 2017;151:2\u201311.","journal-title":"J Proteom."},{"key":"842_CR40","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1021\/pr201258q","volume":"11","author":"S Waldemarson","year":"2012","unstructured":"Waldemarson S, Krogh M, Alaiya A, Kirik U, Schedvins K, Auer G, et al. Protein expression changes in ovarian cancer during the transition from benign to malignant. J Proteome Res. 2012;11:2876\u201389.","journal-title":"J Proteome Res."},{"key":"842_CR41","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1002\/jcb.24250","volume":"113","author":"L-N Wang","year":"2012","unstructured":"Wang L-N, Tong S-W, Hu H-D, Ye F, Li S-L, Ren H, et al. Quantitative proteome analysis of ovarian cancer tissues using a iTRAQ approach. J Cell Biochem. 2012;113:3762\u201372.","journal-title":"J Cell Biochem."},{"key":"842_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.molcel.2008.01.009","volume":"30","author":"JM Harms","year":"2008","unstructured":"Harms JM, Wilson DN, Schluenzen F, Connell SR, Stachelhaus T, Zaborowska Z, et al. Translational regulation via L11: molecular switches on the ribosome turned on and off by thiostrepton and micrococcin. Mol Cell. 2008;30:26\u201338.","journal-title":"Mol Cell"},{"key":"842_CR43","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474: 609\u201315.","DOI":"10.1038\/nature10166"},{"key":"842_CR44","doi-asserted-by":"crossref","first-page":"11365","DOI":"10.18632\/oncotarget.2497","volume":"5","author":"X Zhang","year":"2014","unstructured":"Zhang X, Cheng L, Minn K, Madan R, Godwin AK, Shridhar V, et al. Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells. Oncotarget. 2014;5:11365\u201380.","journal-title":"Oncotarget"},{"key":"842_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1677\/JME-08-0100","volume":"42","author":"T Cristofaro","year":"2009","unstructured":"Cristofaro T, de, Mascia A, Pappalardo A, D\u2019Andrea B, Nitsch L, Zannini M. Pax8 protein stability is controlled by sumoylation. J Mol Endocrinol. 2009;42:35\u201346.","journal-title":"J Mol Endocrinol."}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0842-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0842-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0842-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:16:22Z","timestamp":1684602982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-0842-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":45,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["842"],"URL":"https:\/\/doi.org\/10.1038\/s41388-019-0842-2","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,11]]},"assertion":[{"value":"18 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}